SCHEMBL6289610

SCHEMBL6289610

Cc1ccc(-c2c(N)nn(C)c2O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP7 Q93009 3/20 0.39
HEXA P06865 1/20 0.39
HEXB P07686 1/20 0.39
MAPT P10636 6/20 0.39
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
TP53 P04637 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALDH1A1 P00352 3/20 0.36
TSHR P16473 3/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23399050 0.81 MAPT (0.44) HEXAHEXBMAPTMEN1KMT2A
SCHEMBL23400422 0.80 MAPK14 (0.40) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL23402413 0.76 GCGR (0.40) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL23400427 0.76 LMNA (0.33) MAPTRAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL23399022 0.76 HEXA (0.44) USP7HEXAHEXBMAPTNPC1
SCHEMBL6289612 0.75 MAPT (0.50) USP7HEXAHEXBMAPTMEN1
SCHEMBL23399642 0.75 SMN1; SMN2 (0.48) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL23403034 0.75 SMN1; SMN2 (0.48) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL23399115 0.73 DPP4 (0.40) USP7HEXAHEXBMAPTKMT2A
SCHEMBL23399504 0.70 HTR7 (0.38) USP7MAPTMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962923-B2 Pyrazole compositions PFIZER INC. (US) 2005-11-08 US disclosed
US-20030232848-A1 Pyrazole compositions PFIZER INC. 2003-12-18 US disclosed
US-6573270-B1 Endothelin receptor antagonists PFIZER INC. 2003-06-03 US disclosed
EP-1072597-A1 Pyrazoles and their use as endothelin antagonists Pfizer Limited (GB) 2001-01-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232848-A1 Pyrazole compositions EDNRB, EDNRA, AGTR1 USP7 4478/4885HEXA 4651/4885HEXB 4119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.